Simone L. Verweij

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting

Rutger Verbeek, Renate M. Hoogeveen, Anne Langsted et al. · European Heart Journal · 2018 · 157 citations · Full text

Medicine, Preventive Medicine, Disease Prevention +15

Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in Humans

Sophie J. Bernelot Moens, Simone L. Verweij, Johan G. Schnitzler et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2017 · 143 citations · Full text

Veterinary Medicine, Cardiology, Immunology +17

Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment

Lotte C.A. Stiekema, Erik S.G. Stroes, Simone L. Verweij et al. · European Heart Journal · 2018 · 136 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)

Lotte C.A. Stiekema, Koen H.M. Prange, Renate M. Hoogeveen et al. · European Heart Journal · 2020 · 114 citations · Full text

Veterinary Medicine, Cell Biology, Pharmacology +17

Increased haematopoietic activity in patients with atherosclerosis

Fleur M. van der Valk, Carlijn Kuijk, Simone L. Verweij et al. · European Heart Journal · 2016 · 91 citations · Full text

Medicine, Hematology, Nuclear Medicine +16